Outcome Capital Announces Veranex Has Acquired Boston Healthcare Associates
Retrieved on:
Thursday, June 17, 2021
Professional services, Health, Medical devices, Managed care, Consulting, Pharmaceutical, Biotechnology, Management consulting, Strategic management, Investment banking, Service industries, Economy, Business, Outcome Capital, Boston Healthcare Associates, Veranex, Summit Partners, OUTCOME CAPITAL, BOSTON HEALTHCARE ASSOCIATES, VERANEX, SUMMIT PARTNERS
Outcome Capital, a specialized advisory and investment banking firm that serves middle market companies in the life science and technology segments, today announced that Veranex, a newly formed concept-to-commercialization service provider dedicated to the medtech industry, has acquired Boston Healthcare Associates (BHA), a global strategy consulting firm.
Key Points:
- Outcome Capital, a specialized advisory and investment banking firm that serves middle market companies in the life science and technology segments, today announced that Veranex, a newly formed concept-to-commercialization service provider dedicated to the medtech industry, has acquired Boston Healthcare Associates (BHA), a global strategy consulting firm.
- In conjunction with the acquisition of BHA, Veranex, which was formed in partnership with global growth investors Summit Partners, has acquired two other complementary businesses.
- Outcome Capital served as the exclusive strategic and financial advisor to Boston Healthcare Associate for the transaction.
- Boston Healthcare Associates is a highly specialized, global healthcare consulting firm that helps leading medical device, diagnostic and biopharma clients to unlock the value of innovation.